Maruzen Pharmaceuticals Co., Ltd.
Records under this name other than the patents Maruzen Pharmaceuticals Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 5 of 5 · Back to Maruzen Pharmaceuticals Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,910,557 | Hair care product Term ended Term ended Feb 14, 2026 · USPTO record | Term ended | Term ended Feb 14, 2026 | USPTO record |
| US 8,828,955 | Glutathione production enhancer, prophylactic/therapeutic agent for diseases caused by glutathione deficiency, and food, beverage and feed Lapsed on the fee record Ended Sep 9, 2022 · USPTO record | Lapsed on the fee record | Ended Sep 9, 2022 | USPTO record |
| US 8,563,054 | Anti-inflammatory agent Lapsed on the fee record Ended Oct 22, 2021 · USPTO record | Lapsed on the fee record | Ended Oct 22, 2021 | USPTO record |
| US 6,022,718 | Method of producing capsaicin analogues Lapsed on the fee record Ended Feb 8, 2008 · USPTO record | Lapsed on the fee record | Ended Feb 8, 2008 | USPTO record |
| US 4,448,788 | 11-Deoxoglycyrrhetinic acid hydrogen maleate, process for its production, and its use as a medicine Term ended Term ended no later than May 15, 2004 · Low confidence | Term ended | Term ended no later than May 15, 2004 | Low confidence |